BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20356482)

  • 1. [Evaluating type I interferon-inducible gene expression in patients with systemic lupus erythematosus.].
    Huang J; Li RL; Zhu LN; Sun LY; Feng XB
    Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):45-8. PubMed ID: 20356482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus.
    Feng X; Huang J; Liu Y; Xiao L; Wang D; Hua B; Tsao BP; Sun L
    Clin Rheumatol; 2015 Jan; 34(1):71-9. PubMed ID: 25344775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients.
    Tang J; Gu Y; Zhang M; Ye S; Chen X; Guo Q; Qian J; Bao C; Chen S; Shen N
    Lupus; 2008 Sep; 17(9):805-13. PubMed ID: 18755862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study.
    Ye S; Guo Q; Tang JP; Yang CD; Shen N; Chen SL
    Clin Rheumatol; 2007 Feb; 26(2):186-90. PubMed ID: 16565890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon-inducible genes 2', 5'-ollgoadenylate synthetase-like and tetratricopeptide repeats 2 are correlated with clinical features of patients with systemic lupus erythematosus].
    Zhao ZY; Yang NP; Huang XY; Min L; Liu XX; Zhang J; Ye Y; Shi LJ; Zhong X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):247-51. PubMed ID: 20506645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE.
    Juárez-Vicuña Y; Pérez-Ramos J; Adalid-Peralta L; Sánchez F; Martínez-Martínez LA; Ortiz-Segura MDC; Pichardo-Ontiveros E; Hernández-Díazcouder A; Amezcua-Guerra LM; Ramírez-Bello J; Sánchez-Muñoz F
    Front Genet; 2021; 12():647487. PubMed ID: 34149799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
    Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
    Front Immunol; 2022; 13():962393. PubMed ID: 35967341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.
    Landolt-Marticorena C; Bonventi G; Lubovich A; Ferguson C; Unnithan T; Su J; Gladman DD; Urowitz M; Fortin PR; Wither J
    Ann Rheum Dis; 2009 Sep; 68(9):1440-6. PubMed ID: 18772188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The correlation of myxovirus resistance 1 and 2'5'-ollgoadenylate synthetase 1 with clinical features of systemic lupus erythematosus].
    Li M; Yang NP; Huang XY; Zhao ZY; Zhang J; Liu XX; Pu XY; Dong JL; Ye Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):268-71. PubMed ID: 19462904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    Steiman AJ; Gladman DD; Ibañez D; Noamani B; Landolt-Marticorena C; Urowitz MB; Wither JE
    J Rheumatol; 2015 Dec; 42(12):2318-26. PubMed ID: 26568589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-stimulated gene 15 expression in systemic lupus erythematosus : Diagnostic value and association with lymphocytopenia.
    Yuan Y; Ma H; Ye Z; Jing W; Jiang Z
    Z Rheumatol; 2018 Apr; 77(3):256-262. PubMed ID: 28204879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus.
    Han L; Zhang Y; Wang Q; Xin M; Yang K; Lei K; Sun M
    Lupus; 2018 Jan; ():961203317753069. PubMed ID: 29338588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients.
    El-Karaksy SM; Kholoussi NM; Shahin RM; El-Ghar MM; Gheith Rel-S
    Gene; 2013 Sep; 527(1):211-4. PubMed ID: 23792015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Li D; Song L; Fan Y; Li X; Li Y; Chen J; Zhu F; Guo C; Shi Y; Zhang L
    Clin Immunol; 2009 Dec; 133(3):422-7. PubMed ID: 19748832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1.
    Ye S; Pang H; Gu YY; Hua J; Chen XG; Bao CD; Wang Y; Zhang W; Qian J; Tsao BP; Hahn BH; Chen SL; Rao ZH; Shen N
    Rheumatology (Oxford); 2003 Oct; 42(10):1155-63. PubMed ID: 12777642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.